Expanding therapy for patients with hidradenitis suppurativa.
P012 – New and Emerging Therapies
Friday, July 22 | 1-3 p.m.
Dermatology is taking a fresh look into expanding existing surgical and laser interventions for the management of hidradenitis suppurativa (HS). This afternoon’s session, P012 – New and Emerging Therapies offers hope to the many patients living with the painful lumps deep in their skin.
So Yeon Paek, MD, FAAD, assistant clinical professor of dermatology at Texas A&M College of Medicine in Dallas leads the session, which will detail surgical options for general dermatologists to use in their daily practice. Existing HS surgical therapies include traditional de-roofing, local and wide excisions, and STEEP (skin-tissue-saving excision with electrosurgical peeling).
New MODES for treatment
During the session, Dr. Paek will introduce a novel outpatient procedure called MODES (MOdified Deroofing with Exploratory sinus tract and Scar excision). She will take attendees through step-by-step video instructions for performing the MODES outpatient procedure in their own offices.
“In recent years, developments have been made in the medical treatment of HS, but none are capable of dissolving scar tissue, or the epithelial linings present in chronic sinuses,” Dr. Paek said. “The benefits of a combined medical-surgical approach to treating HS offer patients surgical procedures that may be performed by dermatologists in their offices and may elevate patients’ quality of life and treatment satisfaction with concurrent medical therapy for this difficult-to-treat disease.”
“Our MODES technique is unique in that it combines both an initial de-roofing procedure, followed by exploration and subsequent marsupialization and excision of involved scar tissue,” Dr. Paek said. “We have performed this procedure in a large cohort of patients with great success. Our technique accomplishes many of the key goals in the surgical treatment of HS, including early disease management, reduction of chronic pain, prevention of morbidity, significant tissue loss, recurrent procedures, and prolonged hospital stays.”
The session will encourage a combined surgical and medical approach to treating HS, and will also explore various laser devices and procedures that may be used to treat it. Iltefat Hamzavi, MD, FAAD, a dermatologist at Henry Ford Hospital department of dermatology and Wayne State University in Detroit, will provide a comprehensive review of the Nd:YAG, CO₂ laser, and IPL with radiofrequency devices, among other laser therapies for HS.
Visit AAD DermWorld Meeting News Central for more articles.